HITI vs. DRTS, CGEN, OM, GNFT, ADVM, LFCR, OBIO, TELO, GALT, and GLSI
Should you be buying High Tide stock or one of its competitors? The main competitors of High Tide include Alpha Tau Medical (DRTS), Compugen (CGEN), Outset Medical (OM), Genfit (GNFT), Adverum Biotechnologies (ADVM), Lifecore Biomedical (LFCR), Orchestra BioMed (OBIO), Telomir Pharmaceuticals (TELO), Galectin Therapeutics (GALT), and Greenwich LifeSciences (GLSI). These companies are all part of the "medical" sector.
High Tide (NASDAQ:HITI) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, community ranking, media sentiment, valuation and risk.
High Tide has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 0.75, suggesting that its share price is 25% less volatile than the S&P 500.
In the previous week, Alpha Tau Medical had 2 more articles in the media than High Tide. MarketBeat recorded 4 mentions for Alpha Tau Medical and 2 mentions for High Tide. Alpha Tau Medical's average media sentiment score of 0.89 beat High Tide's score of 0.62 indicating that Alpha Tau Medical is being referred to more favorably in the news media.
Alpha Tau Medical has a net margin of 0.00% compared to High Tide's net margin of -7.46%. High Tide's return on equity of -2.03% beat Alpha Tau Medical's return on equity.
Alpha Tau Medical received 3 more outperform votes than High Tide when rated by MarketBeat users. Likewise, 60.00% of users gave Alpha Tau Medical an outperform vote while only 39.13% of users gave High Tide an outperform vote.
4.5% of High Tide shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 12.4% of High Tide shares are owned by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
High Tide has higher revenue and earnings than Alpha Tau Medical. High Tide is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.
High Tide presently has a consensus price target of $4.50, suggesting a potential upside of 95.65%. Alpha Tau Medical has a consensus price target of $12.00, suggesting a potential upside of 337.96%. Given Alpha Tau Medical's higher probable upside, analysts plainly believe Alpha Tau Medical is more favorable than High Tide.
Summary
Alpha Tau Medical beats High Tide on 10 of the 16 factors compared between the two stocks.
Get High Tide News Delivered to You Automatically
Sign up to receive the latest news and ratings for HITI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HITI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
High Tide Competitors List
Related Companies and Tools
